The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer

Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force

(2013) Kenneth Lin et al.   ANNALS OF INTERNAL MEDICINE

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Utilizing isotope dilution-matrix-assisted laser desorption ionization-time of flight mass spectrometry as a reference procedure for the radioimmunoassay of serum thyroxine

(2012) Yu-Chang Tyan et al.   CLINICA CHIMICA ACTA

Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment

(2012) Valérie Laurent-Matha et al.   FASEB JOURNAL

Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer

(2012) Jean-Nicolas Cornu et al.   PROSTATE

The measurement of a fibrinogen α C-chain 5.9kDa fragment (FIC 5.9) using MALDI-TOF MS and a stable isotope-labeled peptide standard dilution

(2011) Kazuyuki Sogawa et al.   CLINICA CHIMICA ACTA

Utility of the Riskindicator model in screening

(2010) Stacy Loeb et al.   Nature Reviews Urology

Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics

(2009) David Rodríguez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)

(2009) Roger S. Kirby et al.   BJU INTERNATIONAL

Serum proteomics of glioma: methods and applications

(2009) Kumaravel Somasundaram et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates

(2009) Bénédicte Cauwe et al.   Integrative Biology

Prostate-specific antigen-based screening for prostate cancer: Evidence, controversies and future perspectives

(2009) Kazuto Ito   INTERNATIONAL JOURNAL OF UROLOGY

Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease

(2009) Richard R. Drake et al.   Journal of Proteomics

Re: Prostate-Specific Antigen: A Misused and Maligned Prostate Cancer Biomarker

(2009) R. J. Hamilton et al.   JNCI-Journal of the National Cancer Institute

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Applications of SELDI-MS technology in oncology

(2008) L. C. Whelan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Prostate-Specific Antigen: A Misused and Maligned Prostate Cancer Biomarker

(2008) Ian M. Thompson et al.   JNCI-Journal of the National Cancer Institute

Novel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach

(2008) Danmei Xu et al.   MOLECULAR & CELLULAR PROTEOMICS

Protease proteomics: Revealing protease in vivo functions using systems biology approaches

(2008) A DOUCET et al.   MOLECULAR ASPECTS OF MEDICINE

Beyond prostate-specific antigen: alternate serum markers

(2008) M L Ramírez et al.   PROSTATE CANCER AND PROSTATIC DISEASES